CD40LG and COVID-19: Looking at SARS-CoV-2 antibodies seroprevalence, Zambelli et al. [12] studied cancer patients referred to the Bergamo Hospital, one of the epicenters of COVID-19 pandemic in Italy, and found 31% of them as IgG or IgM positive to COVID-19 using standard serological tests.